Apyx Medical Corp APYX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $4.21
- Day Range
- $4.10–4.24
- 52-Week Range
- $1.59–5.08
- Bid/Ask
- $4.10 / $4.15
- Shares Outstanding
- 41.87M
- Market Cap
- $172.73M
- Volume/Avg
- 106,610 / 173,403
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.51
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 205
- Website
- https://apyxmedical.com
Valuation
|
Metric
|
APYX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 15.30 |
Price/Sales | 3.51 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
APYX
|
|---|---|
Quick Ratio | 4.65 |
Current Ratio | 5.80 |
Interest Coverage | −0.75 |
Quick Ratio
APYX
Profitability
|
Metric
|
APYX
|
|---|---|
Return on Assets (Normalized) | −12.44% |
Return on Equity (Normalized) | −74.58% |
Return on Invested Capital (Normalized) | −8.11% |
Return on Assets
APYX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Hqfkzkhcc | Zmrphsh | $154B | |||
| Stryker Corp
SYK
| Gjwfvmdmjn | Vdg | $115B | |||
| Medtronic PLC
MDT
| Ssrmzlq | Rblklv | $100B | |||
| Boston Scientific Corp
BSX
| Pzrqtszd | Sdqymr | $67B | |||
| Edwards Lifesciences Corp
EW
| Jkwndkldp | Trmffz | $50B | |||
| Siemens Healthineers AG ADR
SMMNY
| — | Ttkl | $45B | |||
| Siemens Healthineers AG Registered Shares
SEMHF
| — | Kxj | $45B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Wlnvxxp | Xdwq | $28B | |||
| DexCom Inc
DXCM
| Mkbspjhnm | Nmjqj | $27B | |||
| Koninklijke Philips NV
RYLPF
| Sztdmzhn | Sjmt | $26B |
United States